Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 15,598 | 27,930 | 21,915 | 24,621 | 16,425 |
| Cost of Goods | 8,110 | 14,998 | 15,001 | 15,008 | 11,308 |
| Gross Profit | 7,488 | 12,932 | 6,914 | 9,613 | 5,117 |
| Operating Expenses | 40,307 | 31,847 | 35,029 | 34,001 | 35,559 |
| Operating Income | -32,709 | -17,917 | -28,114 | -24,380 | -30,134 |
| Interest Expense | 267 | 678 | 664 | 644 | 625 |
| Other Income | 34,238 | 18,504 | -345 | 428 | 435 |
| Pre-tax Income | 1,262 | -91 | -29,123 | -24,596 | -30,324 |
| Net Income Continuous | 1,262 | -91 | -29,123 | -24,596 | -30,324 |
| Net Income | $1,262 | $-91 | $-29,123 | $-24,596 | $-30,324 |
| EPS Basic Total Ops | 0.01 | 0.00 | -0.19 | -0.16 | -0.20 |
| EPS Basic Continuous Ops | 0.01 | 0.00 | -0.19 | -0.16 | -0.20 |
| EPS Diluted Total Ops | 0.01 | 0.00 | -0.19 | -0.16 | -0.20 |
| EPS Diluted Continuous Ops | 0.01 | 0.00 | -0.19 | -0.16 | -0.20 |
| EBITDA(a) | $-30,297 | $-15,173 | $-25,383 | $-21,920 | $-27,822 |